drug
ipilimumab + nivolumab
Phase 3updated 3mo agoby Bristol-Myers Squibb Co
Phase 3community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying ipilimumab + nivolumab
- phase2Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors
- phase2Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC
- phase3Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that